Abstract
Since, the first report on cosmetic applications of non-ionic surfactant vesicles by L’Oreal, numerous papers have been published reporting success of niosomes in drug delivery. Niosomes are considered as one of the most successful drug carrier system applying nanotechnology to potentiate the therapeutic efficacy and reduce toxicities of conventional therapies. Niosomes are biodegradable, nontoxic and nonionic surfactants based vesicular drug carriers. The recent advancements in the pharmaceutical research are focused on the development of new delivery systems based on micro or nano-sized carriers to modulate the drug delivery, targeting as well as to improve the drug stability. Niosome are effective drug carrier with the ability of encapsulating both lipophilic and hydrophilic drugs. This laconic review exhaustively focuses on the potential of niosomal drug delivery with special emphasis on their role in drug targeting, advantages and disadvantages, formulation approaches and applications of niosomes in the disease therapy.
Keywords: Cholesterol, drug carrier systems, nanocarrier, niosomes, non-ionic surfactants, supercritical fluids.
Pharmaceutical Nanotechnology
Title:Frontier Lipid-Based Carrier Systems for Drug Targeting: A Laconic Review on Niosomes
Volume: 2 Issue: 3
Author(s): Rajendra Awasthi, Sumit Kumar and Giriraj T. Kulkarni
Affiliation:
Keywords: Cholesterol, drug carrier systems, nanocarrier, niosomes, non-ionic surfactants, supercritical fluids.
Abstract: Since, the first report on cosmetic applications of non-ionic surfactant vesicles by L’Oreal, numerous papers have been published reporting success of niosomes in drug delivery. Niosomes are considered as one of the most successful drug carrier system applying nanotechnology to potentiate the therapeutic efficacy and reduce toxicities of conventional therapies. Niosomes are biodegradable, nontoxic and nonionic surfactants based vesicular drug carriers. The recent advancements in the pharmaceutical research are focused on the development of new delivery systems based on micro or nano-sized carriers to modulate the drug delivery, targeting as well as to improve the drug stability. Niosome are effective drug carrier with the ability of encapsulating both lipophilic and hydrophilic drugs. This laconic review exhaustively focuses on the potential of niosomal drug delivery with special emphasis on their role in drug targeting, advantages and disadvantages, formulation approaches and applications of niosomes in the disease therapy.
Export Options
About this article
Cite this article as:
Awasthi Rajendra, Kumar Sumit and T. Kulkarni Giriraj, Frontier Lipid-Based Carrier Systems for Drug Targeting: A Laconic Review on Niosomes, Pharmaceutical Nanotechnology 2014; 2 (3) . https://dx.doi.org/10.2174/2211738503666150107234904
DOI https://dx.doi.org/10.2174/2211738503666150107234904 |
Print ISSN 2211-7385 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-7393 |
Call for Papers in Thematic Issues
Polymeric nanocarriers in drug delivery
Polymeric nanocarriers play a crucial role in drug delivery due to their versatility, and unique properties for targeting and modifying drug release. Their ability to enhance therapeutic outcomes, reduce side effects, and enable the delivery of drugs in a more targeted and controlled manner made them popular in the last ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Glutamine, Glucose and other Fuels for Cancer
Current Pharmaceutical Design Beyond Oncolytic Virotherapy: Replication-Competent Retrovirus Vectors for Selective and Stable Transduction of Tumors
Current Gene Therapy Recent Progress of Small Molecular VEGFR Inhibitors as Anticancer Agents
Mini-Reviews in Medicinal Chemistry To Explore the Potential Targets and Current Structure-based Design Strategies Utilizing Co-crystallized Ligand to Combat HCV
Current Drug Targets Hematological Targets of Radiation Damage
Current Drug Targets Fluoroquinolones Prophylaxis of Bacterial Infections in Neutropenic Patients: Time to Re-Evaluate
Current Cancer Therapy Reviews Cancer Drug Discovery Targeting Histone Methyltransferases: An Update
Current Medicinal Chemistry Ceramide in Chemotherapy of Tumors
Recent Patents on Anti-Cancer Drug Discovery Protein Degradation by the Ubiquitin-Proteasome Pathway and Organ Fibrosis
Current Medicinal Chemistry The Involvement of Heat Shock Proteins and Related Molecules in the Resistance to Therapies in Breast and Gynecologic Cancer
Current Cancer Therapy Reviews Targeting Indoleamine 2,3-dioxygenase (IDO) to Counteract Tumour- Induced ImmuneDysfunction: From Biochemistry to Clinical Development
Endocrine, Metabolic & Immune Disorders - Drug Targets Leptomeningeal Metastasis: Challenges in Diagnosis and Treatment
Current Cancer Therapy Reviews Different Aspects of Head and Neck Squamous Cell Carcinoma: Cancer Stem Cells, their Niche and Targeted Therapy
Current Stem Cell Research & Therapy Progress in the Discovery of Macrocyclic Histone Deacetylase Inhibitors for the Treatment of Cancer
Current Medicinal Chemistry Functional Imaging Combined with Multi-Detector CT: A Radionuclide Imaging Perspective
Current Medical Imaging Oncogenic LncRNA CASC9 in Cancer Progression
Current Pharmaceutical Design Specific Targeting of Engineered Nanoparticles to Activated Macrophages
Current Nanoscience Replicative Oncolytic Herpes Simplex Viruses in Combination Cancer Therapies
Current Gene Therapy Current Therapeutic Advances in Patients and Experimental Models of Huntington's Disease
Current Drug Targets Toxicity and Relative Biological Effectiveness of Alpha Emitting Radioimmunoconjugates
Current Radiopharmaceuticals